Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 34 of 57
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
NCT02557672
Familial Partial Lipodystrophy Study
NCT02858830
Impact of Massage Therapy on the Quality of Life of Hospice Patients
NCT02880202
Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS)
NCT03113877
Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer
NCT02874014
Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck
NCT02792322
Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
NCT02657928
Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)
NCT02838667
Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers
NCT03094780
Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude
NCT02852473
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
NCT02736695
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
NCT02730546
Addressing Post Cessation Weight Gain
NCT02412631
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
NCT02613299
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
NCT02673021
Stool Microbiome, Pathogens, and Infectious Agents Among Olympic and Elite Athletes
NCT02818413
Exendin-9,39 and Satiety After Bariatric Surgery
NCT02779075
Physical Activity in the Medical Workplace
NCT02794727
Sugammadex vs Placebo to Prevent Residual Neuromuscular Block
NCT02728726
Spinal Stimulation During Exercise in Heart Failure
NCT02659202
A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation
NCT02783690
Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle
NCT02678442
Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma
NCT02730819
Prospective Trial of Subcutaneous Versus Subpectoral 2-Staged Implant-Based Breast Reconstruction
NCT02775409
Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery
NCT02789410
Committed Actions for Successful Aging
NCT02702570
Caring Hand Massage - an Intervention in Cancer Patients Undergoing Chemotherapy in an Outpatient Setting - a Pilot Study
NCT02742415
Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure
NCT02783716
Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Post-operative Pain After Direct Anterior Total Hip Arthroplasty
NCT02904993
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
NCT02765698
Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma
NCT02697344
MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy
NCT02722434
Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma
NCT02492750
Gut Microbiota Changes in Obese Individuals Undergoing Dedicated Lifestyle Modification Programs
NCT02855242
MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty
NCT02739035
Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty
NCT02768597
Treatment of IgG4-Related Disease With Revlimid and Rituximab
NCT02705638
Simulation and Cadaver Workshop for Medical Students
NCT03050281
Weight Gain and Adipose Tissue
NCT02703766
Impact of MayoExpertAdvisor on Provider Adherence
NCT02742545
Exercise Preconditioning and Breast Cancer Cardiotoxicity
NCT02842658
Biofeedback for Wheelchair Users
NCT02700178
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
NCT02619812
Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients
NCT02744209
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
NCT02613312
Mayo Clinic Foregut Surgery Report Card Questionnaire
NCT02708303
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
NCT02680145
Hematopoietic Stem Cell Transplant Survivors Study
NCT02652052
Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer
NCT02598726
A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors
NCT02736786
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.